Literature DB >> 33513630

Is it Possible to Predict Massive Bleeding in Nulliparous Women with Placenta Previa?

Gokcen Orgul1, Sule Goncu Ayhan1, Gulhan Cetinkaya Saracoglu1, Aykan Yucel1.   

Abstract

OBJECTIVE: We evaluated risk factors to determine if there were specific risk factors that could predict massive bleeding in nulliparous women with placenta previa.
METHODS: The participants were classified into two groups. Women with a calculated blood loss ≥ 1,000 mL were included in the massive bleeding group. Women without any signs or symptoms related with hypovolemia or with a calculated bleeding volume < 1,000 mL were categorized into the non-massive bleeding group.
RESULTS: There were 28 patients (40.6%) with massive bleeding and 41 cases (59.4%) with non-massive bleeding. The calculated blood loss and number of cases that required red cell transfusions were statistically different between the groups (< 0.005 and 0.002, respectively). There were no statistically significant differences in terms of maternal or fetal factors, placental location, or delivery characteristics between the two groups.
CONCLUSION: We could not determine the predictive features for massive hemorrhage based on clinical features, delivery features, or placental location. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Entities:  

Year:  2021        PMID: 33513630     DOI: 10.1055/s-0040-1721355

Source DB:  PubMed          Journal:  Rev Bras Ginecol Obstet        ISSN: 0100-7203


  1 in total

1.  The Feasibility and Safety of Temporary Transcatheter Balloon Occlusion of Bilateral Internal Iliac Arteries during Cesarean Section in a Hybrid Operating Room for Placenta Previa with a High Risk of Massive Hemorrhage.

Authors:  Jin-Gon Bae; Young Hwan Kim; Jin Young Kim; Mu Sook Lee
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.